Oxford Biomedica Solutions
Bryan A. is an experienced professional in analytical development with a strong background in biochemistry. Currently serving as a Senior Research Associate 1 at Oxford Biomedica since May 2022, Bryan A. previously held the position of Research Associate 2 in the same department. Prior experience includes working as an Analytical Chemist at Chemic Laboratories Inc. from February 2020 to May 2022, and as a Desktop Support Contractor at MathWorks for a brief period in 2019. Bryan A. began a career in technical support as an ITS Help Desk Analyst 3 at Northeastern University from January 2014 to November 2018 and gained research experience as an Assay Development Research Intern at Quanterix in 2016. Bryan A. earned a Bachelor of Science degree in Biochemistry from Northeastern University between 2013 and 2019.
This person is not in any offices
Oxford Biomedica Solutions
Oxford Biomedica Solutions, LLC is the high-performing, full scope Adeno-Associated Virus (AAV) vector Manufacturing and Innovation joint venture of Oxford Biomedica plc (LSE:OXB) (“Oxford Biomedica” or “the Group”), and Homology Medicines, Inc. (Nasdaq: FIXX) (“Homology”). We offer global pharmaceutical and biotechnology clients innovative manufacturing expertise in AAV and lentiviral-based cell and gene therapies. Oxford Biomedica Solutions LLC provides access to Homology’s innovative and proven end-to-end AAV manufacturing capabilities, and customers also benefit from technical synergies brought in by the Group’s know-how in lentiviral vector manufacturing. This collaborative and complementary vector-based approach has the potential to accelerate our collective mission to improve patients’ lives worldwide.